September 5, 2025BMC Infectious DiseasesOpen Access

Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China

View Full Paper

Ask AI

Bookmark

Authors

HLHuicong LiuSoochow University LZLi‐Ping ZouNankai University JYJiajia YuWannan Medical College

Discussion

Member takes

Implication

Retrospective cohort study shows treatment outcomes and factors affecting elderly patients with RR-TB, highlighting significant risks and complications.

Key Points

Treatment success was achieved in 65.7% of elderly patients with rifampicin-resistant tuberculosis.
Identified predictors of unfavorable outcomes include low BMI, advanced drug resistance, and pre-treatment anemia.
Adverse events were reported in 56.0% of patients, with anemia being the most common complication.
Adjunctive immunotherapy significantly improved treatment outcomes for elderly RR-TB patients.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/68c239a3b210217d6477d41f https://doi.org/10.1186/s12879-025-11491-4

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort study shows treatment outcomes and factors affecting elderly patients with RR-TB, highlighting significant risks and complications.

Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China

Discussion

Member takes

Implication

Key Points

Cite This Study

Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider